Tracking the price of existing biologics when drugs enter the market

Expert Rev Pharmacoecon Outcomes Res. 2019 Aug;19(4):375-377. doi: 10.1080/14737167.2019.1630274. Epub 2019 Jun 12.
No abstract available

Keywords: Biologics; biosimilars; cost; drugs; market.

Publication types

  • Editorial

MeSH terms

  • Biological Products / administration & dosage
  • Biological Products / economics*
  • Biosimilar Pharmaceuticals / administration & dosage
  • Biosimilar Pharmaceuticals / economics*
  • Drug Approval
  • Drug Costs / statistics & numerical data*
  • Humans

Substances

  • Biological Products
  • Biosimilar Pharmaceuticals